Obesity Flashcards

1
Q

Pediatric absorption

A

-gastic acid secretion reaches adult production around 2-3 years of age
-higher serum concentrations of acid-labile drugs
-lower concentrations of weak acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Newborn tummy

A

-gas pH ranges from 6-8 at birth and drops to 1-3 within 24-48 hours
-delayed emptying = slower absorption
-even slower

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

GI tract peds

A

-gastric eemptying slower
-slower absorption
-delayed Tmax
-decreased capacity to absorb sustained-release formulations compared to adults
-reliable uptake of rectally admin drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

pediatrics IM

A

-rare
-dec muscle mass
-poor perfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Skin absorption

A

-inc due to underdeveloped stratum corneum and inc skin hydration
-ratio of BSA to total body weight is highest in newborns and young children = inc exposure of topically applied drugs compared to adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pediatrics Distribution

A

-high total body water
-high ECF volume
-higher volume of distribution of hydrophilic drugs in younger age groups
-body fat
-Protein binding decreased
-need larger doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Protein binding in newborns

A

-dec plasma protein
-lower binding capacity of protein
-dec affinity of proteins for drug binding
-competition for certain binding sites by endogenous compounds
-inc volume of distribution, need larger doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Peds metabolism

A
  1. CYP
  2. Glucuronosyltransferase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Glucuronosyltransferase (UGT)

A

-reduced activity in neonates and young children; adult levels by adolescents
-metabolism enzyme
-uncojugated bilirubin and acetaminophen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

High concentrations unconjugated bilirubin in newborns

A

-can enter the brain and cause brain damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Acetaminophen metabolism

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Peds CrCl

A

-dec in neonates
-inc rapidly to reach max value at 6 months
-remains above adult values thru childhood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Geriatric Population

A

-65 year and older is fastest growing segment
-drug therapy important in older pts
-underrepresentation of older pts in clinical studies (PK studies)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Older adults absorption

A

-oral not altered in advancing age for drugs with passive diffusion-mediated absorption
-dec absorption for drugs req acidic enviroment (azoles)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

older pt GI

A

-inc pH
-delayed emptying
-dec splanchnic blood flow
-dec absorption surface
-dec GI motility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Transdermal absorption old people

A

-good potential for application in older pt
-age-related changes in composition (thinning and dec structural integrity of dermis
-inc sensitivity to transdermal fentanyl in older pt, no dif for buprenorphine
-more research needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

SC absorption older adults

A

-capillaries and lymph channels
-skin blood supply and lymphatic drainage chanfe w age
-insulin has faster onset and shorter duration of action in elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

IM absorption in old pt

A

-not really altered
-reduced muscle mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Pulmonary absorption in old pt

A

-lung anatomy and physiology change w age
-dec surface, elasticity, cap volume, ratio, CO capacity
-inc residual volume
-lower concentrations of isoflurane and sevoflurane (inhaled anesthetics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Drug distribution older adults

A

-changes in body comp
-changes in plasma protein concentrations
-more a1-acid gcp
-less albumin
-changes may not effect exposure
-dec lean body mass, dec water, inc fat
-dec Vd of hydrophilic drugs (digoxin/aminoglycosides)
-inc Vd of lipophilic drugs (benzos)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Phase II metabolism older adults

A

-does not change w age
-glucuronidation, sulfation, acetylation
-liver does change w aging
-may reduce hepatic Cl of high extraction ratio drugs

22
Q

Older adults elimination

A

-dec blood flow, GFR, secretion and reabsorption
-dec cl of drugs eliminated by GFR and active secretion

23
Q

sex differences in PK

A

-differences in exposure between men and women following admin

24
Q

women are 1.5-1.7 likely to develop and ADR compared to men

25
Absorption in women
-GI pH higher in women -transit time longer -bioavailability of alc is greater -(diff in Vd and gastric alcohol dehydrogenase activity) -no difference in BAC
26
Distribution dif in women
-women higher body fat -greater Vd for lipophilic drugs (inc half-life, accumulation, exposure) -smaller Vd for hydrophilic drugs and smaller plasma volume
27
Sex differences in PK
-CYP1A2, CYP2D6 higher in men -CYP3A higher activity in women
28
Elimination differences in sex
-CrCl higher and faster in men
29
Sex differences in PK
-diff not that relevant
30
Obesity
-excess mortality due to obesity-related co-morbidities -adipokines, cytokines, chemokines --> pro-inflammatory state -inc risk of infection -inc prevalence of nosocomial, surgical site, and RTI
31
Effect of obesity on absorption
-absorption not that effected, delayed SQ
32
Distribution in obesity
-physiochem properties of the drug -obesity as a disease: change in plasma protein, dec tissue, inc adipose tissue mass, cardiac output, blood flow
33
Hydrophilic abx
-B-lactams -glycopeptides -aminoglycosides -polymyxins -fosfomycin
34
Lipophilic Abx
-fluoroquinolones -macrolides -lincosamides -tetracyclines -Tigecycline -TMP/SMZ -Rifampin -chloramphenicol
35
Hydrophilic drugs in obese pt
-inc Vd unadjusted for body weight, due to inc body water -adipose 30% water -obese pt tend to hace inc LBW -plasma volume positively correlated w body weight -Regional differences in blood flow between adipose/lean tissues -usually require dosing based on IBW, LBW, AdjBW
36
Lipophilic drugs
-inc Vd, adjusted for body weight in obesity -usually require dosing based on TBW
37
Effect of obesity on metabolism
-obese pt have fatty infiltration in the liver resulting in non-alcoholic fatty liver disease, w w/o liver -consistent and significant inc in cl of CYP2E1 substrates in obesity -dec CYP3A4
38
Renal elimination in obesity
-inc GFR = inc renal cl -co-morbidities could dec it tho -inc secretion
39
Loading Dose (LD)
-primarily based on Vd -weight used to calc LD depends on how the drug distributed
40
If primarily distributed into lean mass
-use IBW
41
If primarily distributed into fat tissue
-use TBW
42
if distributed into both lean and fat tissues
ABW
43
Maintenance Dose
-primarily based on drug Cl -maybe estimated from CrCl
44
Aminoglycoside Dosing in obesity
-correction factor for weight to estimate Vd ranges from 0.37-0.58 -Cl inc due to faster GFP but elimination rate dim
45
Clearance inc in obesity
-correlated w TBW
46
Pharmacodynamics of B-lactam
-time-dependent bactericidal -little to no PAE for gram neg pathogens -target fT>MIC as percentage of dosing
47
Linezolid
-conflicting data in morbid obesity -600mg q12h -q8h id over 40 -1200mg over 60
48
Daptomycin
-dosing based on TBW -inc AUC and Cmax compared to non-obesee pt -use DBW
49
Dosing in obesity
-acyclovir, ganciclovir, foscarnet, liposomal
50
Obesity Dosing for oral antibiotics
-limited data on oral abx for obesity -considerations: max dose, clinical knowledge